• Home
  • immunodeficiency


Primary immunodeficiencies (PIDs) are a group of more than 400 potentially serious disorders that can lead to frequent or severe infections, swellings and autoimmune problems. PIDs can be caused by defects in genes that control the immune system, and may be inherited.  

ASCIA Immunodeficiency Strategy for Australia and New Zealand To be launched in June 2021

Information for Patients, Consumers and Carers

Immunoglobulin replacement therapy (IRT)

SCIg therapy - general information for patients and carers  

Checklist - SCIg equipment  

Checklist - SCIg infusions

Fast Facts about primary immunodeficiency 

COVID-19 and Immunodeficiency 

COVID-19, Immunodeficiency and School Attendance   

Primary immunodeficiency (PIDs)

Severe combined immunodeficiency (SCID)

Common variable immunodeficiency (CVID)

Hereditary angiodema (HAE) - under development

Subcutaneous Immunogobulin (SCIg) Information 

SCIg therapy - general information for patients and carers 

SCIg information handouts for patients and carers (ASCIA member access only)

Guide - Setting up a SCIg service in a hospital 

SCIg Treatment Plan

Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)

Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy 

SCIg Position Statement 

Other Information for Health Professionals

ASCIA Webinar - HAE 

Guidelines – Standardised infusion rates for intravenous immunoglobulin (IVIg) replacement therapy 

Primary immunodeficiencies (PID) Clinical Update 

Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline

Primary immunodeficiencies (PID) e-training 

Hereditary Angioedema (HAE) Position Paper and Management Plan  

ASCIA Immunodeficiency Strategy for Australia and New Zealand 

Content updated May 2021

Mod ASCIA Member
Donate to AIFA
go to NAS website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.